Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

Obesity is a chronic, progressive disease that can lead to serious health complications, reduced quality of life, and ...

If you are someone who has recently managed to shed your extra weight with the help of a new blockbuster GLP-1 drug then you ...

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth ...

Fourteen Gwinnett County public schools have been named AP School Honor Roll Schools by the College Board. The distinction ...

GLP-1 medications, which include Ozempic, Wegovy, Mounjaro and Zepbound, curb appetite and slow the digestion of food, so ...